SPONSOR
Xenon Pharmaceuticals Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Bipolar DisorderBipolar DepressionBipolar I DisorderBipolar II DisorderFocal Onset Seizures
NCT07172516 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Bipolar Disorder
NCT05716100 Phase 3
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Focal Onset Seizures